Rainbow Coral Corp. (OTCBB: RBCC) executives will be on hand this week
at the 124th National Investment Banking Association (NIBA)
Investment Conference in Las Vegas to seek out new partnership
opportunities in the red-hot biotechnology sector.
The conference offers a chance for public and private companies to make
formal presentations to corporations such as RBCC biotech subsidiary
Rainbow Biosciences that are interested in new innovations ripe for
“We’re particularly interested in discovering additional projects that
exhibit short paths to marketability,” said RBCC CEO Patrick Brown. “We
look forward to networking with hungry entrepreneurs and emerging
businesses with the potential to grow our base of assets and increase
RBCC is already hard at work helping to bring incredible new healthcare
technologies to new markets. The company’s joint venture partner, Nano3D
BioSciences (n3D) has developed a revolutionary 3D cell-culturing system
that could soon lead to a breakthrough in cancer research. RBCC has also
finalized joint venture terms with Amarantus BioSciences (OTCBB: AMBS),
makers of a ground-breaking new blood-test diagnostic for Parkinson’s
The company hopes to add to its portfolio of projects for
commercialization at this week’s NIBA conference.
Rainbow BioSciences is dedicated to developing new medical and research
technology innovations to compete alongside companies such as Amgen Inc.
(NASDAQ: AMGN), Cell Therapeutics, Inc. (NASDAQ: CTIC) and Abbott
Laboratories (NYSE: ABT).
For more information on Rainbow BioSciences, please visit www.rainbowbiosciences.com/investors.
Follow us on Twitter at www.twitter.com/RBCCinfo.
About Rainbow BioSciences
Rainbow BioSciences is a division of Rainbow Coral Corp. (OTCBB: RBCC).
The company continually seeks out new partnerships with biotechnology
developers to deliver profitable new medical technologies and
innovations. For more information on our growth-oriented business
initiatives, please visit our website at www.rainbowbiosciences.com.
For investment information and performance data on the company, please
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release contains forward-looking information within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
including statements that include the words "believes," "expects,"
"anticipate" or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of the company
to differ materially from those expressed or implied by such
forward-looking statements. In addition, description of anyone's past
success, either financial or strategic, is no guarantee of future
success. This news release speaks as of the date first set forth above
and the company assumes no responsibility to update the information
included herein for events occurring after the date hereof.